Altered peptidase activities in thyroid neoplasia and hyperplasia

Disease Markers

Volumn 35, Issue 6, 2013, Pages 825-832

  Larrinaga, Gorka ^a,b   Blanco, Lorena ^a,b   Errarte, Peio ^a,b   Beitia, Maider ^a,b   Sanz, Begoña ^a,b   Perez, Itxaro ^a,b   Irazusta, Amaia ^a,b   Sánchez, Clara E ^a   Santaolalla, Francisco ^c   Andrés, Leire ^b,d   López, José I ^b,d  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Biocruces Research Institute   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 OXOPROLYL PEPTIDASE; AMINOPEPTIDASE B; ASPARTYL AMINOPEPTIDASE; DIPEPTIDYL PEPTIDASE IV; MICROSOMAL AMINOPEPTIDASE; PEPTIDASE; PROLYL ENDOPEPTIDASE;

ADULT; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUOROMETRY; FOLLICULAR THYROID ADENOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; NODULAR GOITER; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA; THYROID HYPERPLASIA; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADULT; ANTIGENS, CD13; CARCINOMA, PAPILLARY; DIPEPTIDYL PEPTIDASE 4; FEMALE; GLUTAMYL AMINOPEPTIDASE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PYROGLUTAMYL-PEPTIDASE I; SERINE ENDOPEPTIDASES; THYROID GLAND; THYROID NEOPLASMS;

EID: 84896944734     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/970736     Document Type: Article

References (54)

1. Bahn R. S., Castro M. R., Approach to the patient with nontoxic multinodular goiter. Journal of Clinical Endocrinology and Metabolism 2011 96 5 1202 1212 2-s2.0-79955675599 10.1210/jc.2010-2583
2. Rosai J., Tallini G., Thyroid gland. Rosai and Ackerman's Surgical Pathology 2011 1 10th chapter 9 Edinburgh, UK Elsevier-Mosby 487 564
3. Mete O., Asa S. L., Pitfalls in the diagnosis of follicular epithelial proliferations of the thyroid. Advances in Anatomic Pathology 2012 19 6 363 373 10.1097/PAP.0b013e318271a5ac
4. López J. I., Zabala R., del Cura J. L., Histological diagnosis of the thyroid disease using ultrasound-guided core biopsies. European Thyroid Journal 2013 2 29 36
5. Lloyd R. V., Buehler D., Khanafshar E., Papillary thyroid carcinoma variants. Head and Neck Pathology 2011 5 1 51 56 2-s2.0-79951513849 10.1007/s12105-010-0236-9
6. LiVolsi V. A., Papillary thyroid carcinoma: an update. Modern Pathology 2011 24 supplement 2 S1 S9 10.1038/modpathol.2010.129
7. Hallberg M., Le Grevès P., Nyberg F., Lendeckel U., Hooper N. M., Neuropeptide processing. Proteases in the Brain 2004 New York, NY, USA Springer Science+Business Media 203 234
8. Ino K., Shibata K., Kajiyama H., Kikkawa F., Mizutani S., Regulatory role of membrane-bound peptidases in the progression of gynecologic malignancies. Biological Chemistry 2004 385 8 683 690 2-s2.0-4544273167 10.1515/BC.2004.084
9. Carl-McGrath S., Lendeckel U., Ebert M., Röcken C., Ectopeptidases in tumour biology: a review. Histology and Histopathology 2006 21 12 1339 1353 2-s2.0-33750130732
10. Antczak C., De Meester I., Bauvois B., Ectopeptidases in pathophysiology. Bioessays 2001 23 3 251 260
11. Ito Y., Yoshida H., Kakudo K., Nakamura Y., Kuma K., Miyauchi A., Inverse relationships between the expression of MMP-7 and MMP-11 and predictors of poor prognosis of papillary thyroid carcinoma. Pathology 2006 38 5 421 425 2-s2.0-33749188873 10.1080/00313020600922496
12. Kraiem Z., Korem S., Matrix metalloproteinases and the thyroid. Thyroid 2000 10 12 1061 1069 2-s2.0-0034501336
13. Liang H., Zhong Y., Luo Z., Huang Y., Lin H., Luo M., Zhan S., Xie K., Ma Y., Li Q. Q., Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis. International Journal of Biological Markers 2010 25 1 38 45 2-s2.0-77950985532
14. Maeta H., Ohgi S., Terada T., Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas. Virchows Archiv 2001 438 2 121 128 2-s2.0-0035115332 10.1007/s004280000286
15. Marecko I., Cvejic D., Tatic S., Dragutinovic V., Paunovic I., Savin S., Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma. Cancer Biomark 2011-2012 11 1 49 58
16. De Micco C., Savchenko V., Giorgi R., Sebag F., Henry J.-F., Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. British Journal of Cancer 2008 98 4 818 823 2-s2.0-39449100808 10.1038/sj.bjc.6604194
17. Kotani T., Kawano J., Suganuma T., Hirai K., Umeki K., Aratake Y., Konoe K., Ohtaki S., Immunohistochemical localization of dipeptidyl aminopeptidase IV in thyroid papillary carcinoma. International Journal of Experimental Pathology 1992 73 2 215 222 2-s2.0-0026608591
18. Umeki K., Tanaka T., Yamamoto I., Aratake Y., Kotani T., Sakamoto F., Noguchi S., Ohtaki S., Differential expression of dipeptidyl peptidase IV (CD26) and thyroid peroxidase in neoplastic thyroid tissues. Endocrine Journal 1996 43 1 53 60 2-s2.0-0029872324
19. Blanco L., Larrinaga G., Pérez I., López J. I., Gil J., Agirregoitia E., Varona A., Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma. American Journal of Physiology 2008 294 4 F850 F858 2-s2.0-44949168668 10.1152/ajprenal.00469.2007
20. Pérez I., Varona A., Blanco L., Gil J., Santaolalla F., Zabala A., Ibarguen A. M., Irazusta J., Larrinaga G., Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma. Head and Neck 2009 31 10 1335 1340 2-s2.0-70349331392 10.1002/hed.21099
21. Varona A., Blanco L., López J. I., Gil J., Agirregoitia E., Irazusta J., Larrinaga G., Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma. American Journal of Physiology 2007 292 2 F780 F788 2-s2.0-33846864246 10.1152/ajprenal.00148.2006
22. Larrinaga G., Blanco L., Sanz B., Perez I., Gil J., Unda M., Andrés L., Casis L., The impact of peptidase activity on clear cell renal cell carcinoma survival. American Journal of Physiology 2012 303 12 F1584 F1559
23. Larrinaga G., Perez I., Blanco L., López J. I., Andrés L., Etxezarraga C., Santaolalla F., Zabala A., Varona A., Irazusta J., Increased prolyl endopeptidase activity in human neoplasia. Regulatory Peptides 2010 163 1-3 102 106 2-s2.0-77953915476 10.1016/j.regpep.2010.03.012
24. Kikkawa F., Kajiyama H., Shibata K., Ino K., Nomura S., Mizutani S., Dipeptidyl peptidase IV in tumor progression. Biochimica et Biophysica Acta 2005 1751 1 45 51 2-s2.0-22744435778 10.1016/j.bbapap.2004.09.028
25. Zambotti-Villela L., Yamasaki S. C., Villarroel J. S., Alponti R. F., Silveira P. F., Aspartyl, arginyl and alanyl aminopeptidase activities in the hippocampus and hypothalamus of streptozotocin-induced diabetic rats. Brain Research 2007 1170 112 118 2-s2.0-34548481975 10.1016/j.brainres.2007.07.026
26. Yoshimoto T., Ogita K., Walter R., Post-proline cleaving enzyme. Synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluids of man. Biochimica et Biophysica Acta 1979 569 2 184 192 2-s2.0-0018750650
27. Mantle D., Lauffat B., McDermott J., Gibson A., Characterization of aminopeptidases in human kidney soluble fraction. Clinica Chimica Acta 1990 187 2 105 113 2-s2.0-0025008623 10.1016/0009-8981(90)90336-Q
28. Silveira P. F., Irazusta J., Gil J., Agirregoitia N., Casis L., Interactions among challenges of hydromineral balance, angiotensin-converting enzyme, and cystine aminopeptidase. Peptides 2001 22 12 2137 2144 2-s2.0-0035755738
29. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976 72 1-2 248 254 2-s2.0-0017184389
30. Goossens F., De Meester I., Vanhoof G., Scharpé S., Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids. European Journal of Clinical Chemistry and Clinical Biochemistry 1996 34 1 17 22
31. Liu J. L., Kusinski M., Ilic V., Bignon J., Hajem N., Komorowski J., Kuzdak K., Stepien H., Wdzieczak-Bakala J., Overexpression of the angiogenic tetrapeptide AcSDKP in human malignant tumors. Anticancer Research 2008 28 5 2813 2817 2-s2.0-55749094878
32. Sedo A., Krepela E., Kasafirek E., Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumours and lung parenchyma. Journal of Cancer Research and Clinical Oncology 1991 117 3 249 253 2-s2.0-0025872297
33. Gorrell M. D., Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clinical Science 2005 108 4 277 292 2-s2.0-17144404555 10.1042/CS20040302
34. Bušek P., Malík R., Šedo A., Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer. International Journal of Biochemistry and Cell Biology 2004 36 3 408 421 2-s2.0-0346219110 10.1016/S1357-2725(03)00262-0
35. Grujić M., Renko M., Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions. Cancer Letters 2002 182 2 113 119 2-s2.0-0037190118 10.1016/S0304-3835(02)00086-1
36. Martínez J. M., Prieto I., Ramírez M. J., Cueva C., Alba F., Martínez M., Aminopeptidase activities in breast cancer tissue. Clinical Chemistry 1999 45 10 1797 1802
37. Nanus D. M., Of peptides and peptidases: the role of cell surface peptidases in cancer. Clinical Cancer Research 2003 9 17 6307 6309 2-s2.0-0347594161
38. Thompson M. W., Hersh L. B., Hooper N. M., Lendeckel U., The puromycin-sensitive aminopeptidase. Role in neurological, reproductive, inmunological and proliferative disorders. Aminopeptidases in Biology and Disease 2004 New York, NY, USA Kluwer Academic/Plenum Press 1 15
39. Ishino T., Ohtsuki S., Homma K., Natori S., cDNA cloning of mouse prolyl endopeptidase and its involvement in DNA synthesis by Swiss 3T3 cells. Journal of Biochemistry 1998 123 3 540 545 2-s2.0-0031913776
40. Moreno-Baylach M. J., Felipo V., Männistö P. T., García-Horsman J. A., Expression and traffic of cellular prolyl oligopeptidase are regulated during cerebellar granule cell differentiation, maturation, and aging. Neuroscience 2008 156 3 580 585 2-s2.0-53249090063 10.1016/j.neuroscience.2008.06.072
41. Myöhänen T. T., Venäläinen J. I., Tupala E., Garcia-Horsman J. A., Miettinen R., Männistö P. T., Distribution of immunoreactive prolyl oligopeptidase in human and rat brain. Neurochemical Research 2007 32 8 1365 1374 2-s2.0-34250875718 10.1007/s11064-007-9316-y
42. Hannula M. J., Männistö P. T., Myöhänen T. T., Sequential expression, activity and nuclear localization of prolyl oligopeptidase protein in the developing rat brain. British Journal of Pharmacology 2012 166 3 1097 1113 10.1111/j.1476-5381.2012.01846.x
43. Moreno-Baylach M. J., Puttonen K. A., Tenorio-Laranga J., Venäläinen J. I., Storvik M., Forsberg M. M., García-Horsman J. A., Prolyl endopeptidase is involved in cellular signalling in human neuroblastoma SH-SY5Y cells. NeuroSignals 2011 19 2 97 109 2-s2.0-79958156031 10.1159/000326342
44. DuBois R. N., Leukotriene A4 signaling, inflammation, and cancer. Journal of the National Cancer Institute 2003 95 14 1028 1029 2-s2.0-0042266355
45. Chen X., Li N., Wang S., Hong J., Jiao X., Krasna M. J., Beer D. G., Yang C. S., Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin. Journal of the National Cancer Institute 2003 95 14 1053 1061 2-s2.0-0043095584
46. Ager E. I., Neo J., Christophi C., The renin-angiotensin system and malignancy. Carcinogenesis 2008 29 9 1675 1684 2-s2.0-51849135397 10.1093/carcin/bgn171
47. Malaguti A., Della Casa C., Castorina S., Martelli A. M., Roti E., Martino E., Toni R., Molecular mechanisms for pituitary thyrotroph cell growth. Journal of Endocrinological Investigation 2004 27 6 151 167 2-s2.0-16544394472
48. Zagon I. S., Verderame M. F., McLaughlin P. J., The biology of the opioid growth factor receptor (OGFr). Brain Research Reviews 2002 38 3 351 376 2-s2.0-0036125025 10.1016/S0165-0173(01)00160-6
49. Balogh A., Cadel S., Foulon T., Picart R., Garabedian A. D., Rousselet A., Tougard C., Cohen P., Aminopeptidase B: a processing enzyme secreted and associated with the plasma membrane of rat pheochromocytoma (PC12) cells. Journal of Cell Science 1998 111 2 161 169 2-s2.0-0031884518
50. García-Hornsman J. A., Männistö P. T., Venäläinen J. I., On the role of prolyl oligopeptidase in health and disease. Neuropeptides 2007 41 1 1 24 10.1016/j.npep.2006.10.004
51. Shrimpton C. N., Smith A. I., Lew R. A., Soluble metalloendopeptidases and neuroendocrine signaling. Endocrine Reviews 2002 23 5 647 664 2-s2.0-0036799813 10.1210/er.2001-0032
52. Re R. N., Cook J. L., An intracrine view of angiogenesis. BioEssays 2006 28 9 943 953 2-s2.0-33748925956 10.1002/bies.20459
53. Re R. N., Cook J. L., The intracrine hypothesis: an update. Regulatory Peptides 2006 133 1-3 1 9 2-s2.0-29244463006 10.1016/j.regpep.2005.09.012
54. Re R. N., Cook J. L., Noncanonical intracrine action. Journal of the American Society of Hypertension 2011 5 6 435 448 2-s2.0-81255157608 10.1016/j.jash.2011.07.001